JP2024500335A5 - - Google Patents
Info
- Publication number
- JP2024500335A5 JP2024500335A5 JP2023534635A JP2023534635A JP2024500335A5 JP 2024500335 A5 JP2024500335 A5 JP 2024500335A5 JP 2023534635 A JP2023534635 A JP 2023534635A JP 2023534635 A JP2023534635 A JP 2023534635A JP 2024500335 A5 JP2024500335 A5 JP 2024500335A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- complex according
- seq
- isolated polypeptide
- polypeptide complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063122820P | 2020-12-08 | 2020-12-08 | |
| US63/122,820 | 2020-12-08 | ||
| PCT/US2021/062233 WO2022125562A1 (en) | 2020-12-08 | 2021-12-07 | Peptide compositions and methods for anti-cd3 binding domains |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024500335A JP2024500335A (ja) | 2024-01-09 |
| JP2024500335A5 true JP2024500335A5 (enExample) | 2024-12-12 |
Family
ID=81973732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534635A Pending JP2024500335A (ja) | 2020-12-08 | 2021-12-07 | 抗ｃｄ３結合ドメインのためのペプチド組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240043536A1 (enExample) |
| EP (1) | EP4259177A4 (enExample) |
| JP (1) | JP2024500335A (enExample) |
| KR (1) | KR20230137301A (enExample) |
| CN (1) | CN116981682A (enExample) |
| AU (1) | AU2021396507A1 (enExample) |
| CA (1) | CA3201401A1 (enExample) |
| MX (1) | MX2023006733A (enExample) |
| WO (1) | WO2022125562A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR125758A1 (es) | 2020-04-04 | 2023-08-09 | Janux Therapeutics Inc | Composiciones y métodos relacionados con anticuerpos activados por tumores dirigidos a egfr y antígenos de células efectoras |
| EP4259193A4 (en) | 2020-12-09 | 2025-01-15 | Janux Therapeutics, Inc. | Compositions and methods related to tumor activated antibodies targeting psma and effector cell antigens |
| EP4615514A2 (en) * | 2022-11-10 | 2025-09-17 | Janux Therapeutics, Inc. | Antibodies targeting egfr and cd3 and uses thereof |
| WO2026002279A1 (en) * | 2024-06-28 | 2026-01-02 | Vibrant Pharma Limited | Mask peptide, cleavable substrate, multispecific antibodies and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016014974A2 (en) * | 2014-07-25 | 2016-01-28 | Cytomx Therapeutics, Inc. | Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same |
| US11046745B2 (en) * | 2015-07-14 | 2021-06-29 | BioNTech SE | Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereof |
| AR125758A1 (es) * | 2020-04-04 | 2023-08-09 | Janux Therapeutics Inc | Composiciones y métodos relacionados con anticuerpos activados por tumores dirigidos a egfr y antígenos de células efectoras |
| CA3196726A1 (en) * | 2020-10-30 | 2022-05-05 | Janux Therapeutics, Inc. | Multispecific antibodies for targeting cd28 and pd-l1 and methods of use thereof |
| TW202237653A (zh) * | 2020-12-09 | 2022-10-01 | 美商詹努克斯治療有限公司 | 與經腫瘤活化之靶定trop2及效應細胞抗原之抗體相關之組合物及方法 |
| EP4259193A4 (en) * | 2020-12-09 | 2025-01-15 | Janux Therapeutics, Inc. | Compositions and methods related to tumor activated antibodies targeting psma and effector cell antigens |
-
2021
- 2021-12-07 EP EP21904260.3A patent/EP4259177A4/en active Pending
- 2021-12-07 CN CN202180092543.9A patent/CN116981682A/zh active Pending
- 2021-12-07 KR KR1020237023034A patent/KR20230137301A/ko active Pending
- 2021-12-07 CA CA3201401A patent/CA3201401A1/en active Pending
- 2021-12-07 JP JP2023534635A patent/JP2024500335A/ja active Pending
- 2021-12-07 US US18/256,278 patent/US20240043536A1/en active Pending
- 2021-12-07 AU AU2021396507A patent/AU2021396507A1/en active Pending
- 2021-12-07 MX MX2023006733A patent/MX2023006733A/es unknown
- 2021-12-07 WO PCT/US2021/062233 patent/WO2022125562A1/en not_active Ceased